These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 29715108)
1. 2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition Liu LC; Wu YC; Kuo SC; Ho CT; Way TD; Chen ST Anticancer Res; 2018 May; 38(5):2849-2859. PubMed ID: 29715108 [TBL] [Abstract][Full Text] [Related]
2. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer. Kim MS; Lee WS; Jeong J; Kim SJ; Jin W Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594 [TBL] [Abstract][Full Text] [Related]
3. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells. Sun D; Shen W; Zhang F; Fan H; Xu C; Li L; Tan J; Miao Y; Zhang H; Yang Y; Cheng H Biomed Pharmacother; 2018 May; 101():107-114. PubMed ID: 29477470 [TBL] [Abstract][Full Text] [Related]
4. IL-6 promotes epithelial-to-mesenchymal transition of human peritoneal mesothelial cells possibly through the JAK2/STAT3 signaling pathway. Xiao J; Gong Y; Chen Y; Yu D; Wang X; Zhang X; Dou Y; Liu D; Cheng G; Lu S; Yuan W; Li Y; Zhao Z Am J Physiol Renal Physiol; 2017 Aug; 313(2):F310-F318. PubMed ID: 28490530 [TBL] [Abstract][Full Text] [Related]
5. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349 [TBL] [Abstract][Full Text] [Related]
6. Iron promotes breast cancer cell migration via IL-6/JAK2/STAT3 signaling pathways in a paracrine or autocrine IL-6-rich inflammatory environment. Cheng M; Liu P; Xu LX J Inorg Biochem; 2020 Sep; 210():111159. PubMed ID: 32652260 [TBL] [Abstract][Full Text] [Related]
7. Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling. To NB; Nguyen YT; Moon JY; Ediriweera MK; Cho SK Nutrients; 2020 Jun; 12(6):. PubMed ID: 32503225 [TBL] [Abstract][Full Text] [Related]
8. Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis. Gyamfi J; Lee YH; Min BS; Choi J Sci Rep; 2019 Aug; 9(1):11336. PubMed ID: 31383893 [TBL] [Abstract][Full Text] [Related]
9. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964 [TBL] [Abstract][Full Text] [Related]
10. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells. Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802 [TBL] [Abstract][Full Text] [Related]
11. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma. Miao JW; Liu LJ; Huang J Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843 [TBL] [Abstract][Full Text] [Related]
13. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of NF-kB/IL-6/JAK2/STAT3 Pathway and Epithelial-Mesenchymal Transition in Breast Cancer Cells by Azilsartan. Alaaeldin R; Ali FEM; Bekhit AA; Zhao QL; Fathy M Molecules; 2022 Nov; 27(22):. PubMed ID: 36431925 [TBL] [Abstract][Full Text] [Related]
15. P16 promotes the growth and mobility potential of breast cancer both in vitro and in vivo: the key role of the activation of IL-6/JAK2/STAT3 signaling. Wang L; Zhan X; Shen X; Li M; Yang J; Yu W; Chen H; Jin B; Mao Z Mol Cell Biochem; 2018 Sep; 446(1-2):137-148. PubMed ID: 29388151 [TBL] [Abstract][Full Text] [Related]
16. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350 [TBL] [Abstract][Full Text] [Related]
17. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway. Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999 [TBL] [Abstract][Full Text] [Related]
18. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Gao X; Liu X; Lu Y; Wang Y; Cao W; Liu X; Hu H; Wang H Breast Cancer; 2019 Sep; 26(5):663-671. PubMed ID: 30989585 [TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide induces epithelial-mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway. Qin Y; Zhao P; Chen Y; Liu X; Dong H; Zheng W; Li C; Mao X; Li J Hum Exp Toxicol; 2020 Feb; 39(2):224-234. PubMed ID: 31610697 [TBL] [Abstract][Full Text] [Related]
20. CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway. Wang L; Zhang F; Cui JY; Chen L; Chen YT; Liu BW Oncol Rep; 2018 May; 39(5):2081-2090. PubMed ID: 29565447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]